Molecular farming company continues to test its pork-infused soy in the field.
With its first products starting to reach the market, Moolec Science’s revenues are lifting, to $5.8 million for fiscal 2024, up from less than a million the year before. R&D costs are also rising, but thanks to additional investor infusions, the company’s assets now stand at $34.8 million, the company told investors as it…
Join for free* to continue reading.
You’ll get access to all Alt-Meat has to offer including full access to our web content devoted to the meat alternatives market.
Already a member? Click here to login>>.
*Free for qualified recipients